Chemkart
117.85
+4.80(+4.25%)
Market Cap₹142.61 Cr
PE Ratio5.64
Company Performance:
1D+4.25%
1M-36.84%
6M-54.58%
1Y-54.58%
5Y-54.58%
View Company Insightsright
More news about Chemkart
11Nov 25
Chemkart Reports 14.5% Revenue Growth in H1 FY26, Bolstered by Successful IPO
Chemkart, a nutraceutical raw materials company, reported robust financial results for H1 FY26. Revenue from operations increased by 14.5% to Rs. 10,322.56 lakhs, while profit after tax grew 14.1% to Rs. 1,015.26 lakhs. The company successfully completed its IPO, raising Rs. 6,448 lakhs and strengthening its financial position. Post-IPO net worth rose to Rs. 12,022.41 lakhs, with cash and equivalents at Rs. 4,374.58 lakhs. Chemkart is progressing on its new manufacturing facility at JNPA SEZ and focusing on becoming a fully integrated, export-driven nutraceutical enterprise by FY 2026-27.
11Sept 25
Chemkart India Unveils Robust Growth Strategy and New Manufacturing Facility in Investor Presentation
Chemkart India Limited, a B2B supplier of raw ingredients for nutritional supplements, reported impressive financial growth with a 3-year CAGR of 32.70% in revenue and 64.20% in PAT. The company announced plans for a new greenfield nutraceutical CDMO facility at JNPT SEZ, Maharashtra, focusing on export markets. This facility will offer integrated CDMO operations, including formulation and packaging, with modern technologies and is expected to be operational by FY27. Chemkart currently serves over 500 clients with a diverse portfolio of 150+ ingredients across 10+ product categories.
08Aug 25
Chemkart's Subsidiary EZRM Begins Construction of Advanced Nutraceutical Facility at JNPA SEZ
Chemkart India Limited (CIL) is expanding into manufacturing through its subsidiary, Easy Raw Materials Pvt. Ltd. (EZRM). Construction has begun on a greenfield nutraceutical manufacturing facility at the Jawaharlal Nehru Port Authority Special Economic Zone in Maharashtra. The facility will operate as a Contract Development and Manufacturing Organization, focusing on formulation, packaging, and global exports of health supplements. It will feature advanced technologies like microencapsulation and liposomal delivery systems. Located on a 4,120 sq.m plot leased for 60 years, the facility benefits from proximity to India's largest container port and SEZ policy advantages. The project marks CIL's strategic shift from trading and distribution to becoming an integrated nutraceutical solutions provider.
Chemkart
117.85
+4.80
(+4.25%)
1 Year Returns:-54.58%
Industry Peers
Orkla
606.05
(-0.54%)
Manorama Industries
1,284.70
(-1.61%)
Apis
92.43
(-5.00%)
Krishival Foods
323.45
(-2.81%)
Shri Ahimsa Naturals
236.30
(-1.66%)
Proventus Agrocom
1,250.00
(-1.57%)
Freshara Agro Exports
163.60
(-0.49%)
Pajson Agro
155.50
(-0.61%)
Goyal Salt
149.80
(-5.96%)
Megastar Foods
226.10
(+0.48%)